Maki Takeda

Development of <i>In Vitro</i> Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells

Maki Takeda, Shigeru Miyagawa, Satsuki Fukushima et al. · Tissue Engineering Part C Methods · 2017 · 103 citations · Full text

Tissue Engineering, Cardiac Muscle, Engineering +30

Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy

Shigeru Miyagawa, Satoshi Kainuma, Takuji Kawamura et al. · Frontiers in Cardiovascular Medicine · 2022 · 90 citations · Full text

Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissue

Hiroko Iseoka, Shigeru Miyagawa, Satsuki Fukushima et al. · Tissue Engineering Part A · 2017 · 75 citations · Full text

Tissue Engineering, Cardiac Muscle, Therapeutic Potential +28

Nitric oxide participates in cataract development in selenite-treated rats

Yoshimasa Ito, Tomohiro Nabekura, Maki Takeda et al. · Current Eye Research · 2001 · 62 citations

Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application

Emiko Ito, Shigeru Miyagawa, Maki Takeda et al. · Scientific Reports · 2019 · 54 citations · Full text